Learn on Demand
Considerations in Outpatient Pain Management for Sickle Cell Disease
Presenter: Lindsey Dayer, PharmD, BCACP
View Activity Information

Knowledge Gap: 
The purpose of this activity is to educate healthcare providers with the most up-to-date information on Considerations in Outpatient Pain Management for Sickle Cell Disease.

Target Audience
The target audience includes all healthcare professionals such as physicians, nurses, pharmacists and allied health professionals who would like to learn about Considerations in Outpatient Pain Management for Sickle Cell Disease and how it pertains to their respective profession.

Release and Expiration Dates
9/22/2017 -9/22/2020


1. Identify barriers and challenges to effective pain management
2. Describe pathophysiology of pain in sickle cell disease
3. Discuss importance of a comprehensive pain assessment
4. Describe updates in chronic pain management
5. List available adjuvant agents for neuropathic pain.
6. Explain the Arkansas Prescription Drug Monitoring Program and its use


• Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. The Journal of Pain. 2015;16(8): 769-780.
• Glowacki D. Effective pain management and improvements in patients’ outcomes and satisfaction. Critical Care Nurse. 2015;35(3): 33-42.
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States 2016. JAMA. 2016;315(15): 1624-1645. doi:10.1001/jama.2016.1464
• McCaffery M. Nursing Practice Theories Related to Cognition, Bodily Pain, and Man-environment interactions. Los Angeles, CA: UCLA Students’ Store; 1968.
• https://www.census.gov/quickfacts/table/PST045215/00. Accessed May 13, 2016.
• Chou R, Deyo R, Devine B, et al. The effectiveness and risks of long-term opioid treatment of chronic pain [Evidence Report/Technology Assessment N. 218]. Agency for Healthcare and Quality. http://www.effectivehealthcare.ahrq.gov/ehc/products/557/1971/chronic-pain-opioid-treatment-report-141007.pdf. Accessed May 13, 2016.
• Guideline for the use of chronic opioid therapy in chronic noncancer pain: evidence review. American Pain Society and American Academy of Pain Medicine. http://americanpainsociety.org/uploads/education/guidelines/chronic-opioid-therapy-cncp.pdf. Accessed May 13, 2016
• http://www.fda.gov/drugs/drugsafety/informationbydrugclass/ucm395456.htm
• Chronic pain: symptoms, diagnosis, & treatment. NIH Medline Plus. 2011;6(1): 5-6. https://www.nlm.nih.gov/medlineplus/magazine/issues/spring11/articles/spring11pg5-6.html. Accessed May 17, 2016
• http://www.arkansaspmp.com/
• Opioids and the treatment of chronic pain: Controversies, current status, and future directions. Rosenblum A, et al. Exp Clin Psychopharmacol. Oct 2008; 6(5): 405-16. Accessed at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711509
• McCain K, Cullen, J, King J, Foster H. Aransas Illicit Opioid Crisis. APA Annual Convention. June 2016. [Poster]
• Nihara Y, Zerez CR, Akiyama DS, et al. Oral l-glutamine therapy for sickle cell anemia: subjective clinical improvement and favorable change in red cell NAD redox potential. Am J Hematol. 1998;58(2): 117-121.

Biographical Info

Lindsey Dayer, PharmD, BCACP is currently on faculty as an Assistant Professor of Pharmacy Practice. Her clinical practice sites are within the Winthrop P. Rockefeller Cancer Institute and are the Medical Oncology and Palliative Care Clinics.  She received her PharmD from the University of Arkansas for Medical Sciences in 2009, completed a Pharmacy Practice Residency at UAMS in 2010, and joined the College of Pharmacy faculty in 2010. Her research interests include: pharmacist-directed interventions to improve adherence to medications, specifically oral antineoplastic agents, interventions to improve patient education and promote patient self-efficacy regarding their oral medications, and quality of life related outcomes in patients with cancer and pain related to their disease.

Speaker Disclosures:
The planners, speakers, moderators, peer reviewers and /or panelists of this CE activity have no relevant financial relationships with commercial interests to disclose.

Kim Miller  
Susan Smith Dodson
Mark Jansen

Lindsey Dayer, PharmD, BCACP

Peer Reviewers: 
Kim Miller, MCHES


Instructions to obtain credit:

1.       Launch the activity 
2.       View the entire activity online 
3.       Complete the post-test 
           (must pass the post-test with a score of 65% to receive credit)
           You may retake the post-test if you do not receive a passing score.
4.       Complete Evaluation 
Print certificate or transcript (Available in the “My Profile” tab).

Direct Provider Statement
In support of improving patient care, University of Arkansas for Medical Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statement 
The University of Arkansas for Medical Science Office of Continuing Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Arkansas for Medical sciences designates this enduring activity for a maximum of 1.00 ANCC contact hours. Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation materials.

Disclosure Policy statement

It is the policy of the University of Arkansas for Medical Sciences Office of Continuing Education to ensure balance, independence, objectivity and scientific rigor in all provided and jointly provided educational activities.  All individuals who are in a position to control the content of the educational activity (course/activity, directors, planning committee members, staff, teachers, or authors of CE) must disclose all relevant financial relationships they have with any commercial interest(s) as well as the nature of the relationship.  Financial relationships of immediate family members must also be disclosed, if the nature of the relationship(s) could influence the objectivity of the individual in a position to control the content.  The ACCME describes relevant financial relationships as those in any amount occurring within the past 12 months that create a conflict of interest.  Individuals who refuse to disclose are disqualified from participation in the development, management, presentation, or evaluation of the CE activity.

UAMS Office of Continuing Education

4301 W. Markham #525
Little Rock, AR 72205
Phone: 501-661-7962 Fax: 501-661-7968

Learn On Demand Contact Us:
For information regarding this educational activity or website, please contact

Center for Distance Health
4301 W. Markham #519
Little Rock, AR 72205
Toll Free: 1-
Email: cdheducation@uams.edu


Type:  Internet Activity (Enduring Material)
27 Registered Users
1 Hours> Non-Accredited

1 Credits> Accreditation Council for Continuing Medical Education> AMA PRA Category 1 Credit

1 Contact Hours> American Nurses Credentialing Center> ANCC

1 CECH, 1 CECH> National Commission for Health Education Credentialing, Inc. > CHES